AIMS: Genetic research on substance use disorders usually defines phenotypes as a binary diagnosis, resulting in a loss of information if the disorder is inherently dimensional. The DSM-IV criteria for drug dependence were based on a theoretically dimensional (linear) model. Considerable investigation has been conducted on DSM-IV alcohol criteria, but less is known about the dimensionality of DSM-IV cannabis criteria for abuse and dependence. The aim of this study is to assess whether DSM-IV cannabis dependence (including withdrawal) and abuse criteria fit a linear measure of severity and whether a consumption criterion adds linearly to severity. DESIGN/SETTING/PARTICIPANTS/MEASUREMENTS: Participants were 8172 in the National Epidemiologic Survey on Alcohol and Related Conditions who had ever used cannabis. Wald statistics were used to test whether categorical, dimensional or hybrid forms best fit the data. We examined the following as criterion sets: (1) dependence; (2) dependence and abuse; and (3) dependence, abuse and frequency of use. Validating variables included family history of drug problems, early onset of cannabis use, and antisocial personality disorder. FINDINGS: For cannabis dependence, no evidence was found for categorical or hybrid models; Wald tests indicated that models representing the seven DSM-IV dependence criteria as a linear severity measure best described the association between the criteria and validating variables. However, significant differences from linearity occurred after adding the four cannabis abuse criteria (p=0.03) and the use indicator (p=0.01) for family history and antisocial personality disorder. CONCLUSION: With ample power to detect non-linearity, cannabis dependence was shown to form an underlying continuum of severity. However, adding abuse criteria, with and without a measure of consumption, resulted in a model that differed significantly from linearity for two of the three validating variables. Copyright 2010 Elsevier Ltd. All rights reserved.
AIMS: Genetic research on substance use disorders usually defines phenotypes as a binary diagnosis, resulting in a loss of information if the disorder is inherently dimensional. The DSM-IV criteria for drug dependence were based on a theoretically dimensional (linear) model. Considerable investigation has been conducted on DSM-IV alcohol criteria, but less is known about the dimensionality of DSM-IV cannabis criteria for abuse and dependence. The aim of this study is to assess whether DSM-IV cannabis dependence (including withdrawal) and abuse criteria fit a linear measure of severity and whether a consumption criterion adds linearly to severity. DESIGN/SETTING/PARTICIPANTS/MEASUREMENTS: Participants were 8172 in the National Epidemiologic Survey on Alcohol and Related Conditions who had ever used cannabis. Wald statistics were used to test whether categorical, dimensional or hybrid forms best fit the data. We examined the following as criterion sets: (1) dependence; (2) dependence and abuse; and (3) dependence, abuse and frequency of use. Validating variables included family history of drug problems, early onset of cannabis use, and antisocial personality disorder. FINDINGS: For cannabis dependence, no evidence was found for categorical or hybrid models; Wald tests indicated that models representing the seven DSM-IV dependence criteria as a linear severity measure best described the association between the criteria and validating variables. However, significant differences from linearity occurred after adding the four cannabis abuse criteria (p=0.03) and the use indicator (p=0.01) for family history and antisocial personality disorder. CONCLUSION: With ample power to detect non-linearity, cannabis dependence was shown to form an underlying continuum of severity. However, adding abuse criteria, with and without a measure of consumption, resulted in a model that differed significantly from linearity for two of the three validating variables. Copyright 2010 Elsevier Ltd. All rights reserved.
Authors: Wilson M Compton; Kevin P Conway; Frederick S Stinson; James D Colliver; Bridget F Grant Journal: J Clin Psychiatry Date: 2005-06 Impact factor: 4.384
Authors: L J Bierut; S H Dinwiddie; H Begleiter; R R Crowe; V Hesselbrock; J I Nurnberger; B Porjesz; M A Schuckit; T Reich Journal: Arch Gen Psychiatry Date: 1998-11
Authors: R F Farmer; D B Kosty; J R Seeley; S C Duncan; M T Lynskey; P Rohde; D N Klein; P M Lewinsohn Journal: Psychol Med Date: 2014-05-12 Impact factor: 7.723
Authors: Risë B Goldstein; S Patricia Chou; Sharon M Smith; Jeesun Jung; Haitao Zhang; Tulshi D Saha; Roger P Pickering; W June Ruan; Boji Huang; Bridget F Grant Journal: J Stud Alcohol Drugs Date: 2015-05 Impact factor: 2.582
Authors: Jungeun Olivia Lee; Tiffany M Jones; Rick Kosterman; Isaac C Rhew; Gina S Lovasi; Karl G Hill; Richard F Catalano; J David Hawkins Journal: Drug Alcohol Depend Date: 2017-02-20 Impact factor: 4.492
Authors: Tulshi D Saha; Wilson M Compton; S Patricia Chou; Sharon Smith; W June Ruan; Boji Huang; Roger P Pickering; Bridget F Grant Journal: Drug Alcohol Depend Date: 2011-10-01 Impact factor: 4.492
Authors: Bradley T Kerridge; Tulshi D Saha; Sharon Smith; Patricia S Chou; Roger P Pickering; Boji Huang; June W Ruan; Attila J Pulay Journal: Addict Behav Date: 2011-05-28 Impact factor: 3.913
Authors: Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant Journal: Am J Psychiatry Date: 2013-08 Impact factor: 18.112